<%@ page language="java" import="java.util.*" pageEncoding="UTF-8"%>
<%@ include file="../common/init.jsp"%>
<%
	String pagenav = "AbStop";
	String pagemodel=abstop;
%>
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<title>Pre-designed antibody packages against those most aggressive and comprehensive proteins.</title>
<meta name="keywords" content="antibody, membrane proteins, protein sequences, sequenced organisms, transcription factor, soluble factor, disease biomarker, therapeutic target, plasma protein, phosphosite, alternative spliced junction, mutation, variant, small molecule drug, antibiotics, pesticide" />
<meta name="description" content="AbStop, pre-designed antibody packages against high value targets, best for diagnostics and therapeutic antibody development" />
</head>
<body>
	<script>
	document.getElementById("Default_AbStop").style.fontWeight='bold';
	document.getElementById("Default_AbStop").children[0].children[0].style.color="#FF6600";
</script>
	<div class="localbar">
		<li><a href="<%=home %>" style="color: white">Home</a> > <%=pagenav%></li>
	</div>
	<div class="contentbox">
		<div class="tab">
			<a href="<%=path%>/<%=pagemodel.toLowerCase()%>_overview.html">Overview</a> <a href="<%=path%>/<%=pagemodel.toLowerCase()%>_features.html">Features</a> <a href="#">Technology</a> <a href="<%=path%>/<%=pagemodel.toLowerCase()%>_design.html">Design</a>
		</div>
		<div class="field">
			<a class="h1">Technology</a>
			<p>&nbsp;</p>
			<p>
				AbStop&#8482; is based on <a href="<%=path%>/<%=seal %>_overview.html" target="_blank">SEAL&#8482;</a> technology.
			</p>
			<p>
				<a href="<%=path%>/<%=seal %>_overview.html" target="_blank">SEAL&#8482;</a> is a shot-gun, library approach for deep covering a target’s surface sequences with ultra-high affinity, specific monoclonal antibodies.
			</p>
			<p>
				<a href="<%=path%>/<%=seal %>_overview.html" target="_blank">SEAL&#8482;</a> consists of novel technologies for antigen design, potent immunogen preparation, efficient animal immunization, and large-scale antibody screening to produce high affinity, highly specific antibodies. <a href="<%=path%>/<%=seal %>_overview.html" target="_blank">SEAL&#8482;</a> has proven to be a successful approach for developing antibodies for difficult applications (flow cytometry, IHC, IP and functional) against difficult
				targets such as membrane proteins (GPCRs, ion channels), transcription factors and signaling molecules. Further, we have built an industrialized monoclonal antibody assembly line for making <a href="<%=path%>/<%=seal %>_overview.html" target="_blank">SEAL&#8482;</a> antibodies so that the unit cost for each antibody development is only at a small fraction of traditional approaches. Together, <a href="<%=path%>/<%=seal %>_overview.html" target="_blank">SEAL&#8482;</a>offers an unprecedented freedom and
				success for monoclonal antibody discovery.

			</p>
			<p>
				<a href="<%=path%>/<%=seal %>_overview.html" target="_blank">SEAL&#8482;</a> is becoming a general approach for generating high value application antibodies (flow cytometry, ELISA, IHC and functional) against high value targets including GPCRs, ion channels, difficult membrane proteins, transcription factors.

			</p>
			<p>&nbsp;</p>
			<p>&nbsp;</p>
		</div>
	</div>
</body>
</html>
